Pepric, a spin-off of European chip research centre Imec, successfully concluded a €1.4m capital round.
The start-up develops equipment for quantitative molecular detection and imaging to monitor biological processes evolving slowly over time. These are similar to PET or SPECT scanners to monitor processes evolving slowly over several days or weeks within the body.
Infectious diseases are an example of such processes, or cell therapies for which it can take a few weeks before sufficient cells have migrated to the target tissue.
For slow biological processes, for example when monitoring cell migration it is possible to locate the cells, however it remains difficult to determine the amount of cells having reached the target tissue.
Pepric’s sensitive tools will allow pre-clinical centres to evaluate the efficacy of new therapies and to perform early diagnosis.
The investment will be used to support the production and commercialisation of first product: the analysis tool for quantitative molecular and cellular detection in tissue, urine and blood samples.
It wil also enable Pepric to develop its core technology towards detection and imaging within the body.
www.imec.be